Back to the list
Congress: ECR25
Poster Number: C-16137
Type: Poster: EPOS Radiologist (scientific)
Authorblock: J. Aleem, R. Rai, S. Sattar; Birmingham/UK
Disclosures:
Javaria Aleem: Nothing to disclose
Rupinder Rai: Nothing to disclose
Sandeela Sattar: Nothing to disclose
Keywords: Artificial Intelligence, Breast, Contrast agents, Mammography, MR, Ultrasound, Biopsy, Radiation effects, Teleradiology, Abscess, Cancer, Cysts
Methods and materials

The audit reviewed the factors causing the high VHR screening recall rate in our centre. The recall rate in our department is 12.8%, which should be at least the expected standard rate of 10% and, ideally, the achievable rate of 7%. VHR screening Includes patients with genetically proven genes that increase the risk of breast cancer and those who have had radiotherapy to the chest. A 10-year risk assessment is done, and if the risk is>8%, then screening begins at 28 years of age with an MRI breast only. From 40 years of age, ladies have a breast MRI and mammogram within 6 weeks of each other. From 50 years of age, a decision is made regarding mammogram screening alone or whether an MRI breast is still required1.

A retrospective study included 18 clients who were recalled from January 2022 to June 2023 and underwent MRI breast and mammogram under a very high-risk screening program. Two experienced breast radiologists report MRI breast and mammogram. They were assessed under age, mass, non-mass enhancement only, mass and non-mass enhancement, MRI score, mammogram score, ultrasound assessment score, cancer gene positive, and histology outcome. Data were recorded from the hospital information system (NBSS) and presented in graphical format. 

GALLERY